resazurin has been researched along with paclitaxel in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davies, NM; Forrest, ML; Kwon, GS; Ohgami, Y; Remsberg, CM; Yáñez, JA | 1 |
1 other study(ies) available for resazurin and paclitaxel
Article | Year |
---|---|
Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Chemical Phenomena; Chemistry, Physical; Delayed-Action Preparations; Drug Carriers; Injections, Intravenous; Male; Micelles; Nanoparticles; Octanols; Oxazines; Paclitaxel; Particle Size; Polyesters; Rats; Rats, Sprague-Dawley; Tissue Distribution; Xanthenes | 2008 |